Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

25d ago

VIRX

PremiumCompany Announcements

Viracta Therapeutics CFO Resigns, Interim Successor Appointed

1M ago

VIRX

PremiumPress Releases

Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

2M ago

VIRX

PremiumPress Releases

Viracta Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

3M ago

VIRX

PremiumPress Releases

Viracta Therapeutics Provides Clinical Update and Outlook for 2024

4M ago

VIRX

PremiumPress Releases

Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patients with Epstein-Barr Virus-Positive Solid Tumors that Show Confirmed Tumor Responses at Higher Dose Levels

5M ago

VIRX

PremiumPress Releases

Viracta Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

6M ago

VIRX

More VIRX News >

VIRX News on the Web

2024-04-18

Promising Clinical Trial Results Reinforce Buy Rating for Viracta Therapeutics

TipRanks News

Bullish

2024-04-17

Analysts Offer Insights on Healthcare Companies: Viracta Therapeutics (VIRX) and UnitedHealth (UNH)

TipRanks News

Bullish

2024-04-15

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive Peripheral T-Cell Lymphoma

Yahoo Finance

Neutral

2024-04-01

Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan

Yahoo Finance

Neutral

2024-03-20

Viracta Therapeutics CFO Resigns, Interim Successor Appointed

TipRanks News

Neutral

2024-03-12

Healthcare Stocks on the Move Tuesday: RGLS, LTRN, VIRX, GLSI, LEXX, CRBU, ASLN, VRPX

Investors Observer

Neutral

2024-03-08

VIRX Stock Earnings: Viracta Therapeutics Misses EPS for Q4 2023

InvestorPlace

Neutral

2024-03-07

Viracta Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Yahoo Finance

Neutral

News Score - Last 7 Days

Positive

VIRX

Sector Average

Media Buzz

This Week3 articles

Weekly Average1 articles

News Sentiment

This Week100%

Sector Average62%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VIRX’s Media Buzz Sentiment?

3 articles about VIRX were published this week. In an average week, 1 articles are published.

What is VIRX’s weekly average amount of articles?

In an average week, 1 articles about VIRX are published.

What is VIRX’s News Sentiment?

100% of articles about VIRX were positive this week, compared to its sector average of 62%.

Healthcare Stocks that are Trending in the News

ELVElevance Health

EWEdwards Lifesciences

INSPInspire Medical Systems

CGEMCullinan Management

MRNSMarinus

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing